TABLE 1.
GC Test Visit Positivity by Anatomic Site Among MSM Attending STD Clinics, N = 1 39,718 Visits—STD Surveillance NetWork, 2015–2019
| Jurisdiction | GC Testing at ≥ 1 Anatomic Site at Visit | Urethral GC Testing at Visit | Rectal GC Testing at Visit | Pharyngeal GC Testing at Visit | Extragenital GC Testing at visit* | |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|||||
| Tested | Tested Positive | Tested | Tested Positive | Tested | Tested Positive | Tested | Tested Positive | Tested | Tested Positive | |
|
|
|
|
|
|
|
|
|
|
|
|
| N | n (%) | N | n (%) | N | n (%) | N | n (%) | N | n (%) | |
|
| ||||||||||
| Total | 139,718 | 23,888 | 126,972 | 9703 | 101,466 | 11,745 | 123,326 | 11,330 | 128,767 | 18,527 |
| Weighted total positivity (95% Cl) | 16.7(14.4–19.1) | 7.5 (5.7–93) | 11.8(10.4–13.2) | 9.1 (7.9–10.3) | 14.1 (12.5–15.7) | |||||
| Unweighted positivity by jurisdiction | ||||||||||
| Baltimore, MD | 2214 | 516(23.3) | 2128 | 273 (12.8) | 1315 | 256 (19.5) | 1718 | 195 (14.8) | 1830 | 357 (19.5) |
| Los Angeles County, CA† | 7083 | 1339 (18.9) | 6992 | 505 (7.2) | 4963 | 671 (13.5) | 6363 | 740 (14.9) | 6448 | 1101 (17.1) |
| Miami, FL‡ | 4065 | 542 (13.3) | 3989 | 177(4.4) | 2844 | 257 (9.0) | — | — | 2844 | 257 (9.0) |
| Boston, MA | 1066 | 106 (9.9) | 500 | 18(3.6) | 895 | 77 (8.6) | 1028 | 32 (3.6) | 1040 | 95(9.1) |
| Multnomah County, OR | 8623 | 1296(15.0) | 8391 | 434 (5.2) | 6279 | 699(11.1) | 7802 | 697 (11.1) | 7920 | 1089(13.8) |
| Minneapolis, MN | 17,714 | 2297 (13.0) | 17,361 | 695 (4.0) | 12,762 | 1220 (9.6) | 16,029 | 1287 (10.1) | 16,293 | 1951 (12.0) |
| New York City, NY | 46,495 | 9209 (19.8) | 44,371 | 4363 (9.8) | 33,842 | 4492 (13.3) | 41,576 | 3906 (11.5) | 42,896 | 6825 (15.9) |
| Philadelphia. PA | 9989 | 2394 (24.0) | 9767 | 1060 (10.9) | 6511 | 968 (14.9) | 9434 | 1251 (19.2) | 9530 | 1809 (19.0) |
| San Francisco, CA | 28,448 | 4126(14.5) | 27,568 | 1507 (5.5) | 20,872 | 1936 (9.3) | 25,904 | 2105 (10.1) | 26,371 | 3239 (12.3) |
| Seattle, WA | 14,021 | 2063 (14.7) | 5905 | 671 (11.4) | 11,183 | 1169(10.5) | 13,472 | 1117(10.0) | 13,595 | 1804 (13.3) |
*
Rectal and/or pharyngeal test visit.
†
Data obtained in 2019 from participating clinics were not available for this analysis.
‡
Participating clinics did not perform pharyngeal GC testing.